Orion Capital Management LLC Pfizer Inc Transaction History

Orion Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $46,343 - $53,216	-1,790 Reduced 91.28%	171 $4,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $134,046 - $174,112	-5,130 Reduced 72.35%	1,961 $56,000
Q3 2023 Nov 15, 2023	SELL	$32.09 - $37.51 $93,381 - $109,154	-2,910 Reduced 29.1%	7,091 $235,000
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $89,541 - $103,597	-2,479 Reduced 19.86%	10,001 $366,000
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $11,817 - $15,384	-300 Reduced 2.35%	12,480 $509,000
Q3 2022 Oct 26, 2022	BUY	$43.76 - $53.42 $131,717 - $160,794	3,010 Added 30.81%	12,780 $559,000
Q2 2022 Jul 22, 2022	BUY	$46.53 - $55.17 $46,530 - $55,170	1,000 Added 11.4%	9,770 $512,000
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $108,885 - $134,922	2,380 Added 37.25%	8,770 $454,000
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $20,246 - $30,012	490 Added 8.31%	6,390 $377,000
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $183,140 - $207,468	5,100 Added 637.5%	5,900 $231,000
Q4 2020 Feb 23, 2021	BUY	$33.47 - $42.56 $26,776 - $34,048	800 New	800 $29,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Orion Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Orion Capital Management LLC with notifications on news.